DBV Technologies S.A. (DBVT)

NASDAQ

$9.46

$+0.48

(+5.35%)

Regular Market

DBV Technologies S.A. (DBVT) Live Price Chart

Last updated: ⁦2026-10-20 19:34:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

DBV Technologies S.A. (DBVT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $9.46, with a market capitalization of $568.78M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8.63 to $26.19. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$568.78M
Open	$8.95
Day's High	$505.70
Day's Low	$2.20
Previous Close	$8.97
Volume	193.48K
Average Volume	346.27K
P/E Ratio	--
52-Week High	$26.19
52-Week Low	$8.63
Dividend Yield	--
Earnings Date	--

DBV Technologies S.A. (DBVT) Stock Price Today

DBV Technologies S.A. (DBVT) is currently trading at $9.46 as of 2026-10-20 19:33:00, up 5.46% ($0.49) from the previous close of $8.97

During today's regular trading session, DBVT has traded between $2.20 and $505.70, with a trading volume of 193.48K shares. The current price is near the lower end of today's range.

DBV Technologies S.A. (DBVT) 7-Day Stock Price Change

Over the past seven days, DBV Technologies S.A. (DBVT) moved from $9.80 to $9.46, representing a decline of 3.47% ($0.34).

The stock traded between $8.63 and $9.86 during the period. The latest price is near the upper end of the 7-day range, indicating moderate downward.

The average daily volume was 375.18 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

DBVT 52-Week Price Position

Position in Range: 4.7%

52W Low$8.63

52W High$26.19

DBVT is currently trading at $9.46, placing it 4.7% of the way from its 52-week low of $8.63 to its 52-week high of $26.19. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is DBV Technologies S.A. (DBVT)?

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

DBV Technologies S.A. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	170
Exchange	NASDAQ
Company Website	https://www.dbv-technologies.com

How to Buy DBV Technologies S.A. (DBVT) Stock on MEXC

Eligible investors can buy real shares of DBV Technologies S.A. (DBVT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DBVT and Place Your Order

Open the RealStocks trading page and search for DBVT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is DBV Technologies S.A. (DBVT) stock price today?

DBV Technologies S.A. (DBVT) is currently trading at $ 9.46, up 5.46% ($0.49) from the previous close of $ 8.97. Intraday prices update in real time during regular trading hours.

2.Is DBVT stock going up or down today?

As of 2026-10-20 19:33:00, DBVT is trading at $ 9.46, up 5.46% ($0.49) from its previous close of $ 8.97. The stock has traded between $ 2.20 and $ 505.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is DBVT pre-market price?

As of 2026-10-20 19:33:00, DBVT is trading at $ 8.97 in pre-market trading, up 0.01% ($0.00) from the previous close of $ 8.97. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DBVT after-hours price?

As of 2026-10-20 19:33:00, DBVT is trading at $ 8.98 in after-hours trading, up 0.07% ($0.01) from the regular-session close of $ 8.97. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DBVT stock trading now?

DBVT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DBVT sit relative to its 52-week high and low?

Over the past 52 weeks, DBVT has traded between a low of $ 8.63 and a high of $ 26.19. At $ 9.46, the stock is positioned 4.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is DBV Technologies S.A. in?

DBV Technologies S.A. (DBVT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is DBV Technologies S.A.'s market capitalization and where is it listed?

DBV Technologies S.A. is listed on the NASDAQ exchange with a market capitalization of $ 568.78M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DBVT valued in terms of P/E ratio and EPS?

DBVT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.80. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does DBV Technologies S.A. pay a dividend?

DBV Technologies S.A. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.